Work

Epstein-barr virus-induced hemophagocytic lymphohistiocytosis.

Year: 2013

Type: article

Abstract: Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment.

Source: Europe PMC (PubMed Central)

Authors: K Goudarzipour, M Kajiyazdi, A Mahdaviyani

Institutions: Shahid Beheshti University of Medical Sciences, Masih Daneshvari Hospital

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2167710977

FWCI: 0.866

Cites: 17

Cited by: 34

Related to: 10